Hsing-Wen Wang

Title: Hsing-Wen Wang: Innovator in Kidney Viability Assessment

Introduction

Hsing-Wen Wang is a notable inventor based in Arlington, VA (US). She has made significant contributions to the field of medical technology, particularly in the assessment of transplant kidney viability. Her innovative work has the potential to improve outcomes for kidney transplant patients.

Latest Patents

Hsing-Wen Wang holds a patent for an "Apparatus and methods for non-invasive assessment of transplant kidney viability." This kidney viability assessment system (KVAS) provides objective and reliable tests to assess the viability of transplant or donor kidneys in vivo and predict their post-transplant outcomes. The KVAS includes an optical device augmented by an intelligent algorithm that evaluates the viability or quality of the donor kidney in a real-time, non-invasive manner. Specifically, it features a handheld optical coherence tomography (OCT) imaging device and at least one processor configured to execute a set of instructions corresponding to an automatic image processing algorithm. This algorithm quantifies kidney microstructures and functions, allowing for comprehensive assessment.

Career Highlights

Throughout her career, Hsing-Wen Wang has worked with esteemed institutions such as the University System of Maryland and Georgetown University. Her experience in these organizations has contributed to her expertise in medical technology and innovation.

Collaborations

Hsing-Wen Wang has collaborated with notable individuals in her field, including Peter Andrews and Jeremiah Wierwille. These partnerships have further enhanced her research and development efforts.

Conclusion

Hsing-Wen Wang's contributions to kidney viability assessment technology exemplify her dedication to improving medical outcomes. Her innovative patent and collaborative efforts highlight her role as a leading inventor in this critical area of healthcare.